Clinical Report: Assessment of the Global Impact of Infectious Diseases in Children

Overview

This comprehensive review evaluates the global, regional, and national impact of pathogen-related infectious diseases in children aged 0–14 years from 1990 to 2021. It highlights significant disparities in disease burden across different demographics and regions, emphasizing the ongoing challenges posed by infectious diseases despite improvements in vaccination and healthcare access.

Background

Infectious diseases are a leading cause of morbidity and mortality in children, particularly in low-resource settings. Despite advancements in vaccination programs, significant disparities in disease burden persist, necessitating ongoing evaluation and targeted interventions. Understanding the demographic and geographic variations in disease impact is crucial for informing public health strategies and improving child health outcomes.

Data Highlights

This study utilized data from the Global Burden of Disease (GBD) Study to analyze the contributions of 34 major pathogens to mortality and disability in children aged 0–14 years, with projections extending to 2050.

Key Findings

• Infectious diseases account for a significant portion of disability-adjusted life years (DALYs) in children aged 0–14 years.
• Lower respiratory infections, diarrheal diseases, and meningitis are among the major infectious syndromes affecting children.
• The implementation of pneumococcal conjugate vaccines (PCVs) and rotavirus vaccines has led to reductions in mortality from vaccine-preventable diseases.
• Pathogen-attributable disease burdens remain disproportionately high in low-sociodemographic index (SDI) regions.
• Emerging and re-emerging viral pathogens, along with antimicrobial resistance, pose ongoing challenges for infectious disease control.
• Systematic evaluations of infectious disease burden in children are limited, highlighting the need for comprehensive analyses.

Clinical Implications

Healthcare professionals should be aware of the persistent burden of infectious diseases in children, particularly in low-resource settings. Continued efforts in vaccination and infection control are essential to address these challenges and improve health outcomes for pediatric populations.

Conclusion

The findings from this review underscore the importance of ongoing surveillance and targeted interventions to mitigate the impact of infectious diseases on child health globally.

Related Resources & Content

1. Global Burden of Disease Study 2021 (GBD 2021) Burden and Strength of Evidence by Risk Factor 1990-2021 | GHDx
2. Evolving Patterns of Inflammatory Bowel Disease Among Pediatric and Adolescent Populations
3. Infection — Occurrence of Intestinal Protozoan Parasites in Asian Schoolchildren: A Systematic Review and Meta-Analysis
4. Examining the Increasing Incidence of Inflammatory Bowel Disease in Young Populations Amid Global Changes: Findings from GBD 2021
5. Frontiers in Pediatrics — Long-term epidemiological patterns of pediatric infectious diseases in an urban district of Shanghai, 2015–2023
6. Global childhood vaccination holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF
7. Guideline on management of pneumonia and diarrhoea in children up to 10 years of age
8. Global Burden of Disease Study 2021 (GBD 2021) Burden and Strength of Evidence by Risk Factor 1990-2021 | GHDx